Maven Securities LTD Invitae Corp Transaction History

Maven Securities LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $220,500 - $430,050	-15,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $364,650 - $504,000	15,000 New	15,000 $426,000
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $1.77 Million - $2.75 Million	-67,978 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $2.25 Million - $3.87 Million	67,978 New	67,978 $2.6 Million
Q2 2018 Aug 13, 2018	SELL	$4.87 - $8.42 $1.02 Million - $1.76 Million	-208,768 Closed	0 $0

Q1 2018 May 15, 2018	BUY	$4.69 - $10.05 $979,121 - $2.1 Million	208,768 New	208,768 $979,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.